Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1990 Mar 24;300(6727):793–798. doi: 10.1136/bmj.300.6727.793

New antiviral and antifungal drugs.

P G Davey 1
PMCID: PMC1662554  PMID: 2182165

Full text

PDF
793

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bain V. G., Alexander G. J. Progress in the treatment of chronic hepatitis B virus infection. J Antimicrob Chemother. 1988 Dec;22(6):780–783. doi: 10.1093/jac/22.6.780. [DOI] [PubMed] [Google Scholar]
  2. Clissold S. P., Heel R. C. Tioconazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses. Drugs. 1986 Jan;31(1):29–51. doi: 10.2165/00003495-198631010-00003. [DOI] [PubMed] [Google Scholar]
  3. Corey L., Whitley R. J., Stone E. F., Mohan K. Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet. 1988 Jan 2;1(8575-6):1–4. doi: 10.1016/s0140-6736(88)90997-x. [DOI] [PubMed] [Google Scholar]
  4. Fischl M. A., Richman D. D., Grieco M. H., Gottlieb M. S., Volberding P. A., Laskin O. L., Leedom J. M., Groopman J. E., Mildvan D., Schooley R. T. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul 23;317(4):185–191. doi: 10.1056/NEJM198707233170401. [DOI] [PubMed] [Google Scholar]
  5. Fromtling R. A. Overview of medically important antifungal azole derivatives. Clin Microbiol Rev. 1988 Apr;1(2):187–217. doi: 10.1128/cmr.1.2.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gibson J. R. The treatment of viral warts with interferons. J Antimicrob Chemother. 1988 Apr;21(4):391–393. doi: 10.1093/jac/21.4.391. [DOI] [PubMed] [Google Scholar]
  7. Hanger D. P., Jevons S., Shaw J. T. Fluconazole and testosterone: in vivo and in vitro studies. Antimicrob Agents Chemother. 1988 May;32(5):646–648. doi: 10.1128/aac.32.5.646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hay R. J., Clayton Y. M., Moore M. K. A comparison of tioconazole 28% nail solution versus base as an adjunct to oral griseofulvin in patients with onychomycosis. Clin Exp Dermatol. 1987 May;12(3):175–177. doi: 10.1111/j.1365-2230.1987.tb01888.x. [DOI] [PubMed] [Google Scholar]
  9. Hay R. J., Mackie R. M., Clayton Y. M. Tioconazole nail solution--an open study of its efficacy in onychomycosis. Clin Exp Dermatol. 1985 Mar;10(2):111–115. doi: 10.1111/j.1365-2230.1985.tb00537.x. [DOI] [PubMed] [Google Scholar]
  10. Hayward R. A., Shapiro M. F., Oye R. K. Laboratory testing on cerebrospinal fluid. A reappraisal. Lancet. 1987 Jan 3;1(8523):1–4. doi: 10.1016/s0140-6736(87)90698-2. [DOI] [PubMed] [Google Scholar]
  11. Ho M. Interferon for the treatment of infections. Annu Rev Med. 1987;38:51–59. doi: 10.1146/annurev.me.38.020187.000411. [DOI] [PubMed] [Google Scholar]
  12. Kutzer E., Oittner R., Leodolter S., Brammer K. W. A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis; report of a double-blind multicentre trial. Eur J Obstet Gynecol Reprod Biol. 1988 Dec;29(4):305–313. doi: 10.1016/0028-2243(88)90071-8. [DOI] [PubMed] [Google Scholar]
  13. Lane H. C., Kovacs J. A., Feinberg J., Herpin B., Davey V., Walker R., Deyton L., Metcalf J. A., Baseler M., Salzman N. Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma. Lancet. 1988 Nov 26;2(8622):1218–1222. doi: 10.1016/s0140-6736(88)90811-2. [DOI] [PubMed] [Google Scholar]
  14. McDonald E. M., Mann A. H., Thomas H. C. Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers. Lancet. 1987 Nov 21;2(8569):1175–1178. doi: 10.1016/s0140-6736(87)91319-5. [DOI] [PubMed] [Google Scholar]
  15. McKendrick M. W., McGill J. I., White J. E., Wood M. J. Oral acyclovir in acute herpes zoster. Br Med J (Clin Res Ed) 1986 Dec 13;293(6561):1529–1532. doi: 10.1136/bmj.293.6561.1529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Miles M. R., Olsen L., Rogers A. Recurrent vaginal candidiasis. Importance of an intestinal reservoir. JAMA. 1977 Oct 24;238(17):1836–1837. doi: 10.1001/jama.238.17.1836. [DOI] [PubMed] [Google Scholar]
  17. Mindel A., Faherty A., Carney O., Patou G., Freris M., Williams P. Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes. Lancet. 1988 Apr 23;1(8591):926–928. doi: 10.1016/s0140-6736(88)91725-4. [DOI] [PubMed] [Google Scholar]
  18. Richman D. D., Fischl M. A., Grieco M. H., Gottlieb M. S., Volberding P. A., Laskin O. L., Leedom J. M., Groopman J. E., Mildvan D., Hirsch M. S. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul 23;317(4):192–197. doi: 10.1056/NEJM198707233170402. [DOI] [PubMed] [Google Scholar]
  19. Saag M. S., Dismukes W. E. Azole antifungal agents: emphasis on new triazoles. Antimicrob Agents Chemother. 1988 Jan;32(1):1–8. doi: 10.1128/aac.32.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Scully C. Serum beta 2 microglobulin in recurrent aphthous stomatitis and Behçet's syndrome. Clin Exp Dermatol. 1982 Jan;7(1):61–64. doi: 10.1111/j.1365-2230.1982.tb02386.x. [DOI] [PubMed] [Google Scholar]
  21. Sobel J. D. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 1985 Aug 1;152(7 Pt 2):924–935. doi: 10.1016/s0002-9378(85)80003-x. [DOI] [PubMed] [Google Scholar]
  22. Sullender W. M., Arvin A. M., Diaz P. S., Connor J. D., Straube R., Dankner W., Levin M. J., Weller S., Blum M. R., Chapman S. Pharmacokinetics of acyclovir suspension in infants and children. Antimicrob Agents Chemother. 1987 Nov;31(11):1722–1726. doi: 10.1128/aac.31.11.1722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tomson C. R., Goodship T. H., Rodger R. S. Psychiatric side-effects of acyclovir in patients with chronic renal failure. Lancet. 1985 Aug 17;2(8451):385–386. doi: 10.1016/s0140-6736(85)92517-6. [DOI] [PubMed] [Google Scholar]
  24. Tooley P. J. Patient and doctor preferences in the treatment of vaginal candidosis. Practitioner. 1985 Jul;229(1405):655–660. [PubMed] [Google Scholar]
  25. Tucker R. M., Williams P. L., Arathoon E. G., Levine B. E., Hartstein A. I., Hanson L. H., Stevens D. A. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis. Antimicrob Agents Chemother. 1988 Mar;32(3):369–373. doi: 10.1128/aac.32.3.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Viviani M. A., Tortorano A. M., Langer M., Almaviva M., Negri C., Cristina S., Scoccia S., De Maria R., Fiocchi R., Ferrazzi P. Experience with itraconazole in cryptococcosis and aspergillosis. J Infect. 1989 Mar;18(2):151–165. doi: 10.1016/s0163-4453(89)91178-x. [DOI] [PubMed] [Google Scholar]
  27. Wood M. J., Geddes A. M. Antiviral therapy. Lancet. 1987 Nov 21;2(8569):1189–1193. doi: 10.1016/s0140-6736(87)91329-8. [DOI] [PubMed] [Google Scholar]
  28. de Wit R., Schattenkerk J. K., Boucher C. A., Bakker P. J., Veenhof K. H., Danner S. A. Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma. Lancet. 1988 Nov 26;2(8622):1214–1217. doi: 10.1016/s0140-6736(88)90810-0. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES